Enzymotec Ltd. to Participate in the Canaccord Genuity 34th Annual Growth Conference
31 July 2014 - 10:00PM
Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer,
manufacturer and marketer of innovative bio-active lipid
ingredients, announced today that Dr. Ariel Katz, President and
Chief Executive Officer, and Oren Bryan, Vice President and Chief
Financial Officer, will present at the Canaccord Genuity 34th
Annual Growth Conference on Thursday, August 14, 2014 at 8:30 a.m.
ET in Boston, MA.
The audio portion of Enzymotec's presentation will be webcast
live, and a replay will be available on the Investors section of
the Company's website at www.enzymotec.com.
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio- active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies. For more information, visit www.enzymotec.com.
CONTACT: ICR
Katie Turner
646-277-1228
Katie.Turner@icrinc.com
John Mills
310-954-1105
John.Mills@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles